Chilean scientists seek alcoholism vaccine

Jan 06, 2011

Chilean researchers said Thursday they are developing a vaccine against alcoholism that could be tested on humans starting next year and works by neutralizing an enzyme that metabolizes alcohol.

The genetic therapy is based on , a group of enzymes that metabolize and are thus responsible for , said Juan Asenjo, who heads a team of researchers at Chile's Faculty of Sciences and Mathematics and the private lab Recalcine.

About 20 percent of the Asian population lacks this enzyme and thus experience "such a strong reaction that it discourages consumption," he added.

The vaccine would similarly increase unease, nausea and tachycardia (accelerated heart beat).

"With the vaccine, the desire to consume alcohol will be greatly reduced thanks to these reactions," Asenjo told Radio Cooperativa.

Researchers have already successfully tested the on rats who were dependent on alcohol, and got them to halve their consumption.

"The idea is to have 90-95 percent reduction of consumption for humans," Asenjo said.

It would work like patches or pills that help smokers kick the habit, but with better efficiency by specifically targeting liver cells and avoiding collateral effects on all cells.

This year, researchers plan to focus on mass production of virus cells and conduct tests on animals to determine proper dosage before launching human tests in 2012.

In October, US researchers announced they had discovered a gene variation known as CYP2EI that can protect against alcoholism and could lead to a preventative treatment.

The known as CYP2EI is linked to people's response to alcohol, and for 10 to 20 percent of people who have it, just a few glasses leads them to feeling more drunk than the rest of the population, said University of North Carolina researchers at the Chapel Hill School of Medicine

This CYP2EI gene -- located in the brain, not the liver -- has long been known to hold an enzyme for metabolizing alcohol, and generates molecules known as free radicals. But a specific variant of the gene makes people more sensitive to alcohol, according to University of North Carolina researchers.

Drugs that can be created to induce the CYP2E1 gene could eventually make people more sensitive to or help sober them up if they have had to much, according to that research team.

Explore further: Benzodiazepine sedatives linked to higher rates of mortality compared to propofol

add to favorites email to friend print save as pdf

Related Stories

Scientists find gene linked to alcoholism

Oct 19, 2010

Researchers from the University of North Carolina at Chapel Hill School of Medicine have discovered a gene variant that may protect against alcoholism.

Scientists identify gene that influences alcohol consumption

Dec 05, 2007

A variant of a gene involved in communication among brain cells has a direct influence on alcohol consumption in mice, according to a new study by scientists supported by the National Institute on Alcohol Abuse and Alcoholism ...

Alcohol tolerance 'switch' found

Oct 21, 2009

Researchers at North Carolina State University have found a genetic "switch" in fruit flies that plays an important role in making flies more tolerant to alcohol.

Gene mutation in worms key to alcohol tolerance

Oct 22, 2008

(PhysOrg.com) -- The work follows a study carried out by Oregon Health and Science University, which suggested a link between a gene mutation in mice and tolerance to alcohol. Researchers at Liverpool have ...

Recommended for you

Discovery helps to spot what makes a good drug

2 hours ago

(Medical Xpress)—A new test developed by researchers from the University of Manchester could revolutionise the discovery of new prescription drugs. The test will help determine which drugs are unlikely to work at an early ...

Merck completes sale of consumer unit to Bayer

19 hours ago

Drugmaker Merck said Wednesday that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 ...

Viagra ads target women for first time

Sep 30, 2014

The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.

User comments : 0